DRREDDYNSEDr. Reddy's Laboratories Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 18 Sept, 2025 · 20:40 IST

Promoters transfer 20.58% stake to family trusts

Promoter Below 50pctOwnership Changes View source PDFExplain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹1322.50
prior close
₹1324.70
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)-0.2%+0.2% vs market
Pharmaceuticals peers, median of 153sector+0.1%-0.2% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty 100 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.5
15m
-0.5
30m
-0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0-0.2+0.2+0.1-0.2
Next day
-1.5-0.6-1.0-0.7-0.8
2d
-1.3-0.8-0.5-0.9-0.4
3d
-1.9-1.3-0.5-1.1-0.7
4d
-3.6-2.0-1.6-2.2-1.4
5d
-5.2-3.0-2.1-4.1-1.1
1w
-7.2-3.0-4.2-4.1-3.1
15d
-4.6-0.8-3.7-3.4-1.1
1m
-2.8+1.4-4.2-3.5+0.7
2m
-5.5+2.1-7.6-6.4+1.0
3m
-3.2+1.6-4.8-8.6+5.4
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On September 17, 2025, Satish Reddy Kallam transferred 75,63,062 shares (9.06%) to VSD Family Trust, while G V Prasad transferred 96,09,592 shares (11.51%) to GVP Family Trust. The trusts received 17,17,26,540 shares, or 20.58%, under a SEBI exemption. Promoter holding stayed unchanged at 26.64%, with no change in control or public shareholding.

Likely market impact

No change in promoter ownership, control or public holding, so this is a succession-planning event with no dilution or sale pressure.